Human breast lesions: Characterization with contrast-enhanced in vivo proton MR spectroscopy - Initial results

Radiology

Volumn 220, Issue 1, 2001, Pages 40-46

  Yeung, D K W ^a   Cheung, H S ^a   Tse, G M K ^a  

^a Diagnostic Radiology Organ Imaging   (Hong Kong)

Author keywords

Breast neoplasms, diagnosis. 00.31, 00.32; Magnetic resonance (MR), contrast enhancement, 00.12143; Magnetic resonance (MR), spectroscopy, 00.121411, 00.121413, 00.121415, 00.12143, 00.12145; Metabolism, 00.59

Indexed keywords

CHOLINE; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST LESION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; EQUIPMENT; FEMALE; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0034969284     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.220.1.r01jl0240     Document Type: Article

References (33)

1. MR imaging of the breast with rotating delivery of excitation off resonance: Clinical experience with pathologic correlation
2. Suspect breast lesions: Findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features
3. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation
4. Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography
5. Pharmacokinetic analysis of Gd-DTPA enhancement in dynamic three-dimensional MRI of breast lesions
6. Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions?
7. Breast MR imaging: Interpretation model
8. Studies of human tumors by MRS: A review
9. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy
10. Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy
11. Choline metabolism in breast cancer: 2H-, 13C- and 31P-NMR studies of cells and tumors
12. Human breast lesions: Characterization with proton MR spectroscopy
13. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy
14. In vivo (1)H MRS of normal breast and breast tumors using a dedicated double breast coil
15. Human breast cancer in vivo: H-1 and P-31 MR spectroscopy at 1.5 T
16. 1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast
17. Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy
18. Determination of choline content in breast tumors with H-1 MR spectroscopy: An external standard method
19. In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard
20. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge
21. MRUI: A graphical user interface for accurate routine MRS data analysis
22. Removal of the water resonance from H-1 magnetic resonance spectra
23. Proton MRS after gadolinium contrast agent
24. The effect of gadolinium on quantitative short-echo time single voxel MRS of treated and untreated brain tumors
25. Fine-needle aspiration is limited in the classification of benign breast diseases
26. Medullary carcinoma of the breast: Prevalence and prognostic importance of classical risk factors in breast cancer
27. Prognostic comparison of three classifications for medullary carcinomas of the breast
28. Apoptosis and cell proliferation in medullary carcinoma of the breast: A comparative study between medullary, and non-medullary carcinoma using the TUNEL method and immunohistochemistry
29. Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy
30. Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells
31. Pyruvate utilization, phosphocholine and adenosine triphosphate (ATP) are markers of human breast tumor progression: A 31P- and 13C-nuclear magnetic resonance (NMR) spectroscopy study
32. Uptake of choline by rat mammary-gland epithelial cells
33. Motion correction and lipid suppression for 1H magnetic resonance spectroscopy